Search

everythinglearnresearchcommunity

for

Search:↓

PCOS is a long-term condition that needs more research for better understanding and treatment.

Hair loss can be managed with treatments like minoxidil, finasteride, and others, but there are still gaps in effectiveness and off-label usage is increasing.

Ageratum conyzoides L. extract may effectively and safely treat hair loss.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Testosterone changes important cell communication proteins in pregnant rats' uteruses, which might affect pregnancy success.

FPHL affects hair density and diameter, causing visible hair loss in older women.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Testosterone helps human pancreatic cells increase insulin release.

PCOS is a complex condition that affects women's hormonal balance and metabolism, requiring lifestyle changes and medical management.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Stress and hormones like progesterone can affect absence seizures, but their effects change with different life stages.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

New regenerative treatments for hair loss show promise but need more research for confirmation.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

PCOS affects nearly 25% of female medical and dental students, impacting their academic and social lives.

Hair loss in women is often due to hereditary conditions or stress, and while treatments like minoxidil can help, diagnosis and management require medical guidance.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

PCOS is a common hormonal disorder in women, treated with lifestyle changes, medication, and patient education.

Some women with common hair loss may develop permanent hair loss.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Hormonal changes and conditions like polycystic ovarian syndrome are major causes of adult acne in women, with varying prevalence among different ethnicities.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.